About Sage Bracket

About

Sage Bracket is an independent information resource that helps people distinguish established dementia evidence from unproven ibogaine claims. Our work focuses on careful context, safety awareness, and plain-language explanations for families and clinicians navigating complex information.

We organize content so readers can move from concise overviews to original source material; our site links directly to registry records, peer-reviewed literature, and published clinical guidance where available. For example, our editorial pages sometimes reference external patient or experience archives such as ibogaine trip reports when they are useful for illustrating variability in experiences, while noting their limits.

Explore how we present evidence

Close-up detail view related to a clinical brief about ibogaine and dementia, textured photographic study

Our editorial approach

We aim to surface evidence quality clearly: distinguishing randomized trials, registered protocols, and systematic reviews from anecdote and unverified claims. Our methodology favors primary sources—registries and peer-reviewed journals—alongside authoritative summaries from recognized institutions. Where appropriate we point readers to context-setting resources such as the National Library of Medicine's registry entries or methodological primers; for instance, general registry practices are described on pages like the clinical trial overview on Wikipedia.

How we source and vet information

Content is curated from public trial registries, indexed literature, and documentary sources. We verify citations against original articles and registry entries, and we flag uncertain or preliminary findings. To support transparency in methodology, we cite external standards and norms for clinical evidence, such as guidance from established research bodies; readers can consult central references like NIH guidance for background on research conduct.

Editorial principles

  • Evidence before claims — prioritize higher-quality, replicable findings.
  • Safety awareness — foreground potential harms and uncertainties.
  • Plain language — explain technical material clearly for caregivers.
  • Scientific uncertainty — explicitly note where data are limited.
  • Respect for caregivers — prioritize actionable context over promotion.

What we cover

We publish concise briefs, summaries of clinical evidence, and navigational guides that help non-specialists find primary sources. Our coverage emphasizes summaries of study design, outcome measures, and safety signals rather than treatment recommendations. When we reference experiential archives or networks to illustrate public discourse, we link directly to such sources—examples include sites that host participant reports like first-person trip reporting archives—always with context about selection bias and reliability.

Because discussions about ibogaine are international, our editorial pages sometimes note service-provider directories or region-specific reporting, such as listings that appear on sites focusing on clinics or centers in different countries; readers will find contextual links to platforms like regional ibogaine resources in Thailand or service directories such as Canadian treatment directories, presented as informational context rather than endorsements.

Independent by design

Our mission is to help people separate established dementia evidence from unproven ibogaine claims. We do not claim to be a clinic, medical provider, or licensed treatment center. If you are evaluating care options, consult a qualified clinician and the original research records we cite.

To navigate other parts of the site, our editorial pages link between sections; for example, the About page links to our main summaries and evidence hub and to our services overview where readers can find descriptions of the resources we publish. We also link selectively to firsthand reporting archives such as military experience collections when relevant, noting selection limits.